Navigation Links
Global Health and Business Leaders Announce 36-Month Effort to Expand Malaria Control in Africa; 3.5 Million Lives Could be Saved in Five Years, Study Finds
Date:1/25/2008

DAVOS, Switzerland, Jan. 25 /PRNewswire/ -- 3.5 million lives could be saved over the next five years through the rapid scale-up of malaria prevention and treatment measures in the 30 hardest hit countries in Africa, according to a new report released today at the World Economic Forum. Additionally, rapid scale-up would increase annual economic output by as much as $30 billion in Africa, prevent 672 million malaria cases, and free up 427,000 needed hospital beds over five years.

"We Can't Afford to Wait: The Business Case for Rapid Scale-up of Malaria Control in Africa," was prepared by Malaria No More and McKinsey & Company on behalf of the Roll Back Malaria Partnership (RBM). Providing specific cost and impact data as part of a rigorous business analysis, the report makes a compelling humanitarian and economic case for expanded access to proven malaria-control tools such as long-lasting insecticide-treated mosquito nets, life-saving anti-malarial medicines, and targeted insecticide spraying.

Current spending on malaria control in Africa is roughly $1 billion a year. The Malaria No More/McKinsey & Company report estimates that prevention and treatment measures could be brought to scale in the 30 African countries that together account for roughly 90 percent of global malaria deaths for approximately $2.2 billion a year over five years. This is an achievable and justifiable investment that would produce vastly superior results than the current trajectory, the report concludes.

Field studies show that as coverage levels rise, infection rates drop off more quickly, creating a situation of increasing returns. In comparison to the current projected growth in coverage, a rapid scale-up effort would save an additional two and a half million lives, prevent an additional 430 million malaria cases, and generate $20 billion more in annual GDP after five years. Rapid scale-up would also be far more cost-effective, saving twice as many lives for ever
'/>"/>

SOURCE Malaria No More
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. Weight Watchers to Present at Credit Suisse 10th Annual Global Services Conference
2. New CDC Global Survey Finds Tobacco Taking Massive Toll on Worlds Children
3. Global Sales Veteran Jack McGovern Joins MediKeeper
4. Fleishman-Hillard Names FFI Global Cause for 2008
5. Lighting up the powerful global smoking lobby
6. Global Pharmaceutical Launches: Best Practices for Winning Product Launch Successes
7. Global Environment partners provide additional $20 million to protect endangered habitats
8. Academic Alliance Foundation Announces Publishing of Global HIV/AIDS Medicine
9. NPR, Harris Corporation and Towson University Launch Global Effort To Make Radio Accessible to Hearing and Sight Impaired
10. Global Med Technologies(R) Adds Eighth SafeTrace Tx(R) Client in New York State
11. Chindex International, Inc. Announces Transfer to NASDAQ Global Market

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/30/2009)...O A large proportion of patients who undergo abdo...dicated and unnecessary additional image acquisiti...re, according to a study presented today at the an...America (RSNA). , "It is the responsibility of a...ensure that the dosage is as low as reasonably ach...
(Date:11/29/2009)..., ATLANTA, Nov. 29 The followin...livest Securities Research, Inc. ,, Intellivest...stered investment advisor, has published a Report ... in the pharmaceutical, biotechnology and medical ...heir clients manage, process and submit medical im...
(Date:11/29/2009)...ng someone get blamed for something leads to more ... , SUNDAY, Nov. 29 (HealthDay News) -- The bl... even when the target is innocent. , Researcher... else for a problem, even if it,s an unfair accusa...g others, too. , "When we see others protectin...
(Date:11/28/2009)... , CHICAGO, Nov. 28 Welcome to...solution for the clinical routine from Siemens H...Communications System (PACS) from Siemens where ... syngo .plaza is poised to change the way mul...ling this innovation at the 95th Scientific Asse...
(Date:11/27/2009)..., BEDFORD, Mass., Nov. 27 /PRNewswire-FirstCall...any"), a supplier of precision technology products...n annual meeting of the Company,s shareholders has...ime and location of the meeting will be announced ...ny received a requisition notice from Stephen Bers...
Breaking Medicine News(10 mins):Health News:Unindicated CT series result in unnecessary radiation exposure for patients 2Health News:Unindicated CT series result in unnecessary radiation exposure for patients 3Health News:Research Report on BioClinica, Inc. as Speculative Buy 2Health News:When Accusations Start to Fly, They Multiply 2Health News:Siemens Healthcare Unveils syngo.plaza at RSNA 2009 2Health News:Siemens Healthcare Unveils syngo.plaza at RSNA 2009 3Health News:GSI Group Calls Shareholders Meeting 2
...fering from Insomnia , , LOS ANGELES, March 31 F...ng and negative impact than a lost night,s sleep. ...nd the endless array of other daily responsibiliti...nfortunately, many women are doing just that, and ...
...vides Extensive Services & Support , , SAN FR...xperienced provider of in home support and recover... its San Francisco location. Interim HomeStyle Se...r from illness. , , The San Francisco location w...
... top, industry employers across North Carolina , ...h 31, 2009 -- BioSpace , the leading resource for...e seventh edition of the Bio NC Hotbed Campaign ...Research Triangle Park and other areas of North Ca...
...FACP is in the private practice of internal medici... the best doctors in New Jersey by New Jersey Mont...;Top Doctor" accolade for the third consecuti... year in the November, 2008 issue of New Jersey Mo...
...laxoSmithKline plc (NYSE: GSK ) has entered into..., Nasdaq: SHPGY ) for Vy v a n s e(R) , to...lt Attention Deficit Hyperactivity Disorder (ADHD)...in discovering and developing medicines to treat p...
...nuts sold in at least 31 states , , MONDAY...Administration officials said Monday night that th...on that could involve 1 million pounds of pistachi... said. , "We are not dealing with an outbreak here...
Other Medicine News:Health News:Tired of Sleepless Nights? 2Health News:Nation's Largest Home Care Provider Welcomes New Management Team to San Francisco Office 2Health News:BioSpace Launches the 2009 Bio NC™ Hotbed Campaign 2Health News:Dr Howard Holtz Named New Jersey Top Doctor for Third Consecutive Year 2Health News:GlaxoSmithKline and Shire Enter Agreement to Co-Promote Vyvanse(R) (lisdexamfetamine dimesylate) CII for Adult Attention Deficit Hyperactivity Disorder 2Health News:GlaxoSmithKline and Shire Enter Agreement to Co-Promote Vyvanse(R) (lisdexamfetamine dimesylate) CII for Adult Attention Deficit Hyperactivity Disorder 3Health News:GlaxoSmithKline and Shire Enter Agreement to Co-Promote Vyvanse(R) (lisdexamfetamine dimesylate) CII for Adult Attention Deficit Hyperactivity Disorder 4Health News:GlaxoSmithKline and Shire Enter Agreement to Co-Promote Vyvanse(R) (lisdexamfetamine dimesylate) CII for Adult Attention Deficit Hyperactivity Disorder 5Health News:GlaxoSmithKline and Shire Enter Agreement to Co-Promote Vyvanse(R) (lisdexamfetamine dimesylate) CII for Adult Attention Deficit Hyperactivity Disorder 6Health News:FDA Investigating Salmonella-Tainted Pistachios 2
(Date:11/25/2009)... , PHILADELPHIA, Nov. 25 /PRNewswire-Fir...hat Dr. Michael J. McKelvey, the Company,s Preside...tive Vice President and CFO, are scheduled to pres...onference at 1:30 PM EST on December 1, 2009 in Ne...y access the presentation by visiting the Company,...
(Date:11/25/2009)... , BRIDGEWATER, N.J., Nov. 25 ...® (etravirine) tablets, a non-nucleoside reve...the only NNRTI specifically indicated for use in t...irologic failure with HIV-1 strains resistant to a...e traditional approval is based on 48-week data fr...
(Date:11/25/2009)... , RANCHO CORDOVA, Calif., Nov. 25 /PRNewswir... of American Pacific Corporation (Nasdaq: APFC ) ... Responsibility and Sustainability Award at the An...the California Manufacturers and Technology Associ...tion (IEA) and the Chemical Industry Council of Ca...
Breaking Medicine Technology:ERT to Present at the 21st Annual Piper Jaffray Health Care Conference on December 1, 2009 2U.S. Food And Drug Administration (FDA) Grants Traditional Approval for INTELENCE(R) (etravirine) 2U.S. Food And Drug Administration (FDA) Grants Traditional Approval for INTELENCE(R) (etravirine) 3U.S. Food And Drug Administration (FDA) Grants Traditional Approval for INTELENCE(R) (etravirine) 4U.S. Food And Drug Administration (FDA) Grants Traditional Approval for INTELENCE(R) (etravirine) 5AMPAC Fine Chemicals Receives Prestigious Award at California's Annual Statewide Environmental Summit 2AMPAC Fine Chemicals Receives Prestigious Award at California's Annual Statewide Environmental Summit 3Chindex International Inc to Report Second Quarter Fiscal 2010 Financial Results 5675 1Chindex International Inc to Report Second Quarter Fiscal 2010 Financial Results 5675 2Dr Siegal 26apos 3Bs Cookie Diet Book by Obesity Expert Sanford Siegal D O M D Cracks Amazon Top 500 60049 1Dr Siegal 26apos 3Bs Cookie Diet Book by Obesity Expert Sanford Siegal D O M D Cracks Amazon Top 500 60049 2Dr Siegal 26apos 3Bs Cookie Diet Book by Obesity Expert Sanford Siegal D O M D Cracks Amazon Top 500 60049 3Dr Siegal 26apos 3Bs Cookie Diet Book by Obesity Expert Sanford Siegal D O M D Cracks Amazon Top 500 60049 4FDA Determines VYVANSE 28R 29 was Properly Granted Five Year Market Exclusivity 5672 1FDA Determines VYVANSE 28R 29 was Properly Granted Five Year Market Exclusivity 5672 2FDA Determines VYVANSE 28R 29 was Properly Granted Five Year Market Exclusivity 5672 3
...26 The Blumenthal,Cancer Center at Carolinas Medi...he Moffitt Cancer Center in a study that could lea...of cancer. CMC is the first hospital system,outsid... Over the next five years, CMC will enroll more t...e collecting tissue samples, medical histories,and...
...26 Pharmacopeia,(Nasdaq: PCOP ), an innovator in...cule therapeutics, today announced the completion ... 2a clinical study of PS433540 (DARA),the company,...f the Phase,2a randomized, double-blind, placebo-c... efficacy and safety of 200 and 500 mg of PS433540...
Other Medicine Technology:CMC, Moffitt Partner to Study Cancer 2Pharmacopeia Completes Enrollment in Phase 2 Hypertension Study with PS433540 (DARA) 2Pharmacopeia Completes Enrollment in Phase 2 Hypertension Study with PS433540 (DARA) 3Pharmacopeia Completes Enrollment in Phase 2 Hypertension Study with PS433540 (DARA) 4
ABL800 FLEX Blood Gas Analyzer
Flatbed Agitator PFS84
Flatbed Agitator PFS42
...telet agitators offer a wide range of storage capa... storage platform to agitate smoothly, eliminating...ueak. Sturdy, one-piece perforated drawers with no...ation for your platelets., ,i.Series platelet ...
Medicine Products: